Member of the Drug and Safety Monitoring Board of the EU FP7 funded INMiND-02 clinical trial. A double-blind, placebo-controlled study of the effect of a TNF alpha inhibitor, etanercept (Enbrel), on microglial activation in amyloid PET positive patients with Mild Cognitive Impairment due to AD-Intermediate likelihood